Risk factors and effective management of preeclampsia - PubMed (original) (raw)

Review

Risk factors and effective management of preeclampsia

Fred A English et al. Integr Blood Press Control. 2015.

Abstract

Preeclampsia, a hypertensive disorder of pregnancy is estimated to complicate 2%-8% of pregnancies and remains a principal cause of maternal and fetal morbidity and mortality. Preeclampsia may present at any gestation but is more commonly encountered in the third trimester. Multiple risk factors have been documented, including: family history, nulliparity, egg donation, diabetes, and obesity. Significant progress has been made in developing tests to predict risk of preeclampsia in pregnancy, but these remain confined to clinical trial settings and center around measuring angiogenic profiles, including placental growth factor or newer tests involving metabolomics. Less progress has been made in developing new treatments and therapeutic targets, and aspirin remains one of the few agents shown to consistently reduce the risk of developing preeclampsia. This review serves to discuss recent advances in risk factor identification, prediction techniques, and management of preeclampsia in antenatal, intrapartum, and postnatal patients.

Keywords: prediction; pregnancy; risk reduction; treatment.

PubMed Disclaimer

Similar articles

• Management of preeclampsia.
  Dekker GA. Dekker GA. Pregnancy Hypertens. 2014 Jul;4(3):246-7. doi: 10.1016/j.preghy.2014.04.021. Epub 2014 Jul 9. Pregnancy Hypertens. 2014. PMID: 26104648
• First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia.
  Nzelu D, Biris D, Karampitsakos T, Nicolaides KK, Kametas NA. Nzelu D, et al. Am J Obstet Gynecol. 2020 Apr;222(4):374.e1-374.e9. doi: 10.1016/j.ajog.2019.10.101. Epub 2019 Nov 6. Am J Obstet Gynecol. 2020. PMID: 31705883
• Low-Dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].
  Henderson JT, Whitlock EP, O'Conner E, Senger CA, Thompson JH, Rowland MG. Henderson JT, et al. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Apr. Report No.: 14-05207-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Apr. Report No.: 14-05207-EF-1. PMID: 24783270 Free Books & Documents. Review.
• Does low-dose aspirin initiated before 11 weeks' gestation reduce the rate of preeclampsia?
  Chaemsaithong P, Cuenca-Gomez D, Plana MN, Gil MM, Poon LC. Chaemsaithong P, et al. Am J Obstet Gynecol. 2020 May;222(5):437-450. doi: 10.1016/j.ajog.2019.08.047. Epub 2019 Sep 5. Am J Obstet Gynecol. 2020. PMID: 31494125
• [Modern methods of early screening for preeclampsia and pregnancy-induced hypertension--a review].
  Poprawski G, Wender-Ozegowska E, Zawiejska A, Brazert J. Poprawski G, et al. Ginekol Pol. 2012 Sep;83(9):688-93. Ginekol Pol. 2012. PMID: 23342898 Review. Polish.

Cited by

• The Pivotal Role of the Placenta in Normal and Pathological Pregnancies: A Focus on Preeclampsia, Fetal Growth Restriction, and Maternal Chronic Venous Disease.
  Ortega MA, Fraile-Martínez O, García-Montero C, Sáez MA, Álvarez-Mon MA, Torres-Carranza D, Álvarez-Mon M, Bujan J, García-Honduvilla N, Bravo C, Guijarro LG, De León-Luis JA. Ortega MA, et al. Cells. 2022 Feb 6;11(3):568. doi: 10.3390/cells11030568. Cells. 2022. PMID: 35159377 Free PMC article. Review.
• Prevalence of preeclampsia and the associated risk factors among pregnant women in Bangladesh.
  Mou AD, Barman Z, Hasan M, Miah R, Hafsa JM, Das Trisha A, Ali N. Mou AD, et al. Sci Rep. 2021 Oct 29;11(1):21339. doi: 10.1038/s41598-021-00839-w. Sci Rep. 2021. PMID: 34716385 Free PMC article.
• Insufficient iodine nutrition status and the risk of pre-eclampsia: a protocol for systematic review and meta-analysis.
  Businge CB, Madini N, Longo-Mbenza B, Kengne AP. Businge CB, et al. BMJ Open. 2019 May 24;9(5):e025573. doi: 10.1136/bmjopen-2018-025573. BMJ Open. 2019. PMID: 31129578 Free PMC article.
• Predicting preeclampsia and related risk factors using data mining approaches: A cross-sectional study.
  Manoochehri Z, Manoochehri S, Soltani F, Tapak L, Sadeghifar M. Manoochehri Z, et al. Int J Reprod Biomed. 2021 Dec 13;19(11):959-968. doi: 10.18502/ijrm.v19i11.9911. eCollection 2021 Nov. Int J Reprod Biomed. 2021. PMID: 34977453 Free PMC article.
• Glycemic control assessed by continuous glucose monitoring during pregnancy in women with type 1 diabetes and its association with preeclampsia, an observational Swedish cohort study.
  Englund Ögge L, Dotevall A, Elfvin A, Sandgren U, Linden K, Bohlin L, Wallstersson B, Sjödell M, Augustinsson J, Hagman A. Englund Ögge L, et al. Acta Obstet Gynecol Scand. 2024 Jul;103(7):1426-1436. doi: 10.1111/aogs.14856. Epub 2024 May 9. Acta Obstet Gynecol Scand. 2024. PMID: 38725185 Free PMC article.

References

1. 1. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol. 1988;158(4):892–898. - PubMed
2. 1. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376(9741):631–644. - PubMed
3. 1. Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980–2010: age-period-cohort analysis. BMJ. 2013;347:f6564. - PMC - PubMed
4. 1. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PFA. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367(9516):1066–1074. - PubMed
5. 1. CESDI . Confidential Enquiry into Stillbirths and Death in Infancy. 5th Annual Report. London, UK: Maternal and Child Health Research Consortium; 1998.

Publication types

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Dove Medical Press
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database